Medical Care
Global Transthyretin Amyloidosis (ATTR) Market Research Report 2025
- Sep 09, 25
- ID: 494223
- Pages: 71
- Figures: 77
- Views: 18
This report aims to provide a comprehensive presentation of the global market for Transthyretin Amyloidosis (ATTR), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transthyretin Amyloidosis (ATTR).
The Transthyretin Amyloidosis (ATTR) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transthyretin Amyloidosis (ATTR) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transthyretin Amyloidosis (ATTR) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Alnylam Pharmaceuticals
Ionis Pharmaceuticals
Corino Therapeutics
Proclara Bioscience
Arcturus Therapeutics
Segment by Type
Hereditary ATTR (HATTR)
Wild-Type (WT) ATTR
Segment by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transthyretin Amyloidosis (ATTR) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Transthyretin Amyloidosis (ATTR) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transthyretin Amyloidosis (ATTR) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transthyretin Amyloidosis (ATTR) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Alnylam Pharmaceuticals
Ionis Pharmaceuticals
Corino Therapeutics
Proclara Bioscience
Arcturus Therapeutics
Segment by Type
Hereditary ATTR (HATTR)
Wild-Type (WT) ATTR
Segment by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transthyretin Amyloidosis (ATTR) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transthyretin Amyloidosis (ATTR) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Hereditary ATTR (HATTR)
1.2.3 Wild-Type (WT) ATTR
1.3 Market by Application
1.3.1 Global Transthyretin Amyloidosis (ATTR) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transthyretin Amyloidosis (ATTR) Market Perspective (2020-2031)
2.2 Global Transthyretin Amyloidosis (ATTR) Growth Trends by Region
2.2.1 Global Transthyretin Amyloidosis (ATTR) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Transthyretin Amyloidosis (ATTR) Historic Market Size by Region (2020-2025)
2.2.3 Transthyretin Amyloidosis (ATTR) Forecasted Market Size by Region (2026-2031)
2.3 Transthyretin Amyloidosis (ATTR) Market Dynamics
2.3.1 Transthyretin Amyloidosis (ATTR) Industry Trends
2.3.2 Transthyretin Amyloidosis (ATTR) Market Drivers
2.3.3 Transthyretin Amyloidosis (ATTR) Market Challenges
2.3.4 Transthyretin Amyloidosis (ATTR) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transthyretin Amyloidosis (ATTR) Players by Revenue
3.1.1 Global Top Transthyretin Amyloidosis (ATTR) Players by Revenue (2020-2025)
3.1.2 Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Players (2020-2025)
3.2 Global Transthyretin Amyloidosis (ATTR) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Transthyretin Amyloidosis (ATTR) Revenue
3.4 Global Transthyretin Amyloidosis (ATTR) Market Concentration Ratio
3.4.1 Global Transthyretin Amyloidosis (ATTR) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transthyretin Amyloidosis (ATTR) Revenue in 2024
3.5 Global Key Players of Transthyretin Amyloidosis (ATTR) Head office and Area Served
3.6 Global Key Players of Transthyretin Amyloidosis (ATTR), Product and Application
3.7 Global Key Players of Transthyretin Amyloidosis (ATTR), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Transthyretin Amyloidosis (ATTR) Breakdown Data by Type
4.1 Global Transthyretin Amyloidosis (ATTR) Historic Market Size by Type (2020-2025)
4.2 Global Transthyretin Amyloidosis (ATTR) Forecasted Market Size by Type (2026-2031)
5 Transthyretin Amyloidosis (ATTR) Breakdown Data by Application
5.1 Global Transthyretin Amyloidosis (ATTR) Historic Market Size by Application (2020-2025)
5.2 Global Transthyretin Amyloidosis (ATTR) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Transthyretin Amyloidosis (ATTR) Market Size (2020-2031)
6.2 North America Transthyretin Amyloidosis (ATTR) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Transthyretin Amyloidosis (ATTR) Market Size by Country (2020-2025)
6.4 North America Transthyretin Amyloidosis (ATTR) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Transthyretin Amyloidosis (ATTR) Market Size (2020-2031)
7.2 Europe Transthyretin Amyloidosis (ATTR) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Transthyretin Amyloidosis (ATTR) Market Size by Country (2020-2025)
7.4 Europe Transthyretin Amyloidosis (ATTR) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transthyretin Amyloidosis (ATTR) Market Size (2020-2031)
8.2 Asia-Pacific Transthyretin Amyloidosis (ATTR) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Transthyretin Amyloidosis (ATTR) Market Size by Region (2020-2025)
8.4 Asia-Pacific Transthyretin Amyloidosis (ATTR) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Transthyretin Amyloidosis (ATTR) Market Size (2020-2031)
9.2 Latin America Transthyretin Amyloidosis (ATTR) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Transthyretin Amyloidosis (ATTR) Market Size by Country (2020-2025)
9.4 Latin America Transthyretin Amyloidosis (ATTR) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transthyretin Amyloidosis (ATTR) Market Size (2020-2031)
10.2 Middle East & Africa Transthyretin Amyloidosis (ATTR) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Transthyretin Amyloidosis (ATTR) Market Size by Country (2020-2025)
10.4 Middle East & Africa Transthyretin Amyloidosis (ATTR) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Transthyretin Amyloidosis (ATTR) Introduction
11.1.4 Pfizer Revenue in Transthyretin Amyloidosis (ATTR) Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 Alnylam Pharmaceuticals
11.2.1 Alnylam Pharmaceuticals Company Details
11.2.2 Alnylam Pharmaceuticals Business Overview
11.2.3 Alnylam Pharmaceuticals Transthyretin Amyloidosis (ATTR) Introduction
11.2.4 Alnylam Pharmaceuticals Revenue in Transthyretin Amyloidosis (ATTR) Business (2020-2025)
11.2.5 Alnylam Pharmaceuticals Recent Development
11.3 Ionis Pharmaceuticals
11.3.1 Ionis Pharmaceuticals Company Details
11.3.2 Ionis Pharmaceuticals Business Overview
11.3.3 Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Introduction
11.3.4 Ionis Pharmaceuticals Revenue in Transthyretin Amyloidosis (ATTR) Business (2020-2025)
11.3.5 Ionis Pharmaceuticals Recent Development
11.4 Corino Therapeutics
11.4.1 Corino Therapeutics Company Details
11.4.2 Corino Therapeutics Business Overview
11.4.3 Corino Therapeutics Transthyretin Amyloidosis (ATTR) Introduction
11.4.4 Corino Therapeutics Revenue in Transthyretin Amyloidosis (ATTR) Business (2020-2025)
11.4.5 Corino Therapeutics Recent Development
11.5 Proclara Bioscience
11.5.1 Proclara Bioscience Company Details
11.5.2 Proclara Bioscience Business Overview
11.5.3 Proclara Bioscience Transthyretin Amyloidosis (ATTR) Introduction
11.5.4 Proclara Bioscience Revenue in Transthyretin Amyloidosis (ATTR) Business (2020-2025)
11.5.5 Proclara Bioscience Recent Development
11.6 Arcturus Therapeutics
11.6.1 Arcturus Therapeutics Company Details
11.6.2 Arcturus Therapeutics Business Overview
11.6.3 Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Introduction
11.6.4 Arcturus Therapeutics Revenue in Transthyretin Amyloidosis (ATTR) Business (2020-2025)
11.6.5 Arcturus Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transthyretin Amyloidosis (ATTR) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Hereditary ATTR (HATTR)
1.2.3 Wild-Type (WT) ATTR
1.3 Market by Application
1.3.1 Global Transthyretin Amyloidosis (ATTR) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transthyretin Amyloidosis (ATTR) Market Perspective (2020-2031)
2.2 Global Transthyretin Amyloidosis (ATTR) Growth Trends by Region
2.2.1 Global Transthyretin Amyloidosis (ATTR) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Transthyretin Amyloidosis (ATTR) Historic Market Size by Region (2020-2025)
2.2.3 Transthyretin Amyloidosis (ATTR) Forecasted Market Size by Region (2026-2031)
2.3 Transthyretin Amyloidosis (ATTR) Market Dynamics
2.3.1 Transthyretin Amyloidosis (ATTR) Industry Trends
2.3.2 Transthyretin Amyloidosis (ATTR) Market Drivers
2.3.3 Transthyretin Amyloidosis (ATTR) Market Challenges
2.3.4 Transthyretin Amyloidosis (ATTR) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transthyretin Amyloidosis (ATTR) Players by Revenue
3.1.1 Global Top Transthyretin Amyloidosis (ATTR) Players by Revenue (2020-2025)
3.1.2 Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Players (2020-2025)
3.2 Global Transthyretin Amyloidosis (ATTR) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Transthyretin Amyloidosis (ATTR) Revenue
3.4 Global Transthyretin Amyloidosis (ATTR) Market Concentration Ratio
3.4.1 Global Transthyretin Amyloidosis (ATTR) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transthyretin Amyloidosis (ATTR) Revenue in 2024
3.5 Global Key Players of Transthyretin Amyloidosis (ATTR) Head office and Area Served
3.6 Global Key Players of Transthyretin Amyloidosis (ATTR), Product and Application
3.7 Global Key Players of Transthyretin Amyloidosis (ATTR), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Transthyretin Amyloidosis (ATTR) Breakdown Data by Type
4.1 Global Transthyretin Amyloidosis (ATTR) Historic Market Size by Type (2020-2025)
4.2 Global Transthyretin Amyloidosis (ATTR) Forecasted Market Size by Type (2026-2031)
5 Transthyretin Amyloidosis (ATTR) Breakdown Data by Application
5.1 Global Transthyretin Amyloidosis (ATTR) Historic Market Size by Application (2020-2025)
5.2 Global Transthyretin Amyloidosis (ATTR) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Transthyretin Amyloidosis (ATTR) Market Size (2020-2031)
6.2 North America Transthyretin Amyloidosis (ATTR) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Transthyretin Amyloidosis (ATTR) Market Size by Country (2020-2025)
6.4 North America Transthyretin Amyloidosis (ATTR) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Transthyretin Amyloidosis (ATTR) Market Size (2020-2031)
7.2 Europe Transthyretin Amyloidosis (ATTR) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Transthyretin Amyloidosis (ATTR) Market Size by Country (2020-2025)
7.4 Europe Transthyretin Amyloidosis (ATTR) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transthyretin Amyloidosis (ATTR) Market Size (2020-2031)
8.2 Asia-Pacific Transthyretin Amyloidosis (ATTR) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Transthyretin Amyloidosis (ATTR) Market Size by Region (2020-2025)
8.4 Asia-Pacific Transthyretin Amyloidosis (ATTR) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Transthyretin Amyloidosis (ATTR) Market Size (2020-2031)
9.2 Latin America Transthyretin Amyloidosis (ATTR) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Transthyretin Amyloidosis (ATTR) Market Size by Country (2020-2025)
9.4 Latin America Transthyretin Amyloidosis (ATTR) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transthyretin Amyloidosis (ATTR) Market Size (2020-2031)
10.2 Middle East & Africa Transthyretin Amyloidosis (ATTR) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Transthyretin Amyloidosis (ATTR) Market Size by Country (2020-2025)
10.4 Middle East & Africa Transthyretin Amyloidosis (ATTR) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Transthyretin Amyloidosis (ATTR) Introduction
11.1.4 Pfizer Revenue in Transthyretin Amyloidosis (ATTR) Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 Alnylam Pharmaceuticals
11.2.1 Alnylam Pharmaceuticals Company Details
11.2.2 Alnylam Pharmaceuticals Business Overview
11.2.3 Alnylam Pharmaceuticals Transthyretin Amyloidosis (ATTR) Introduction
11.2.4 Alnylam Pharmaceuticals Revenue in Transthyretin Amyloidosis (ATTR) Business (2020-2025)
11.2.5 Alnylam Pharmaceuticals Recent Development
11.3 Ionis Pharmaceuticals
11.3.1 Ionis Pharmaceuticals Company Details
11.3.2 Ionis Pharmaceuticals Business Overview
11.3.3 Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Introduction
11.3.4 Ionis Pharmaceuticals Revenue in Transthyretin Amyloidosis (ATTR) Business (2020-2025)
11.3.5 Ionis Pharmaceuticals Recent Development
11.4 Corino Therapeutics
11.4.1 Corino Therapeutics Company Details
11.4.2 Corino Therapeutics Business Overview
11.4.3 Corino Therapeutics Transthyretin Amyloidosis (ATTR) Introduction
11.4.4 Corino Therapeutics Revenue in Transthyretin Amyloidosis (ATTR) Business (2020-2025)
11.4.5 Corino Therapeutics Recent Development
11.5 Proclara Bioscience
11.5.1 Proclara Bioscience Company Details
11.5.2 Proclara Bioscience Business Overview
11.5.3 Proclara Bioscience Transthyretin Amyloidosis (ATTR) Introduction
11.5.4 Proclara Bioscience Revenue in Transthyretin Amyloidosis (ATTR) Business (2020-2025)
11.5.5 Proclara Bioscience Recent Development
11.6 Arcturus Therapeutics
11.6.1 Arcturus Therapeutics Company Details
11.6.2 Arcturus Therapeutics Business Overview
11.6.3 Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Introduction
11.6.4 Arcturus Therapeutics Revenue in Transthyretin Amyloidosis (ATTR) Business (2020-2025)
11.6.5 Arcturus Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Transthyretin Amyloidosis (ATTR) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Hereditary ATTR (HATTR)
Table 3. Key Players of Wild-Type (WT) ATTR
Table 4. Global Transthyretin Amyloidosis (ATTR) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Transthyretin Amyloidosis (ATTR) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Transthyretin Amyloidosis (ATTR) Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Transthyretin Amyloidosis (ATTR) Market Share by Region (2020-2025)
Table 8. Global Transthyretin Amyloidosis (ATTR) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Transthyretin Amyloidosis (ATTR) Market Share by Region (2026-2031)
Table 10. Transthyretin Amyloidosis (ATTR) Market Trends
Table 11. Transthyretin Amyloidosis (ATTR) Market Drivers
Table 12. Transthyretin Amyloidosis (ATTR) Market Challenges
Table 13. Transthyretin Amyloidosis (ATTR) Market Restraints
Table 14. Global Transthyretin Amyloidosis (ATTR) Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Transthyretin Amyloidosis (ATTR) Market Share by Players (2020-2025)
Table 16. Global Top Transthyretin Amyloidosis (ATTR) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transthyretin Amyloidosis (ATTR) as of 2024)
Table 17. Ranking of Global Top Transthyretin Amyloidosis (ATTR) Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Transthyretin Amyloidosis (ATTR) Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Transthyretin Amyloidosis (ATTR), Headquarters and Area Served
Table 20. Global Key Players of Transthyretin Amyloidosis (ATTR), Product and Application
Table 21. Global Key Players of Transthyretin Amyloidosis (ATTR), Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Transthyretin Amyloidosis (ATTR) Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Type (2020-2025)
Table 25. Global Transthyretin Amyloidosis (ATTR) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Type (2026-2031)
Table 27. Global Transthyretin Amyloidosis (ATTR) Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Application (2020-2025)
Table 29. Global Transthyretin Amyloidosis (ATTR) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Application (2026-2031)
Table 31. North America Transthyretin Amyloidosis (ATTR) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Transthyretin Amyloidosis (ATTR) Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Transthyretin Amyloidosis (ATTR) Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Transthyretin Amyloidosis (ATTR) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Transthyretin Amyloidosis (ATTR) Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Transthyretin Amyloidosis (ATTR) Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Transthyretin Amyloidosis (ATTR) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Transthyretin Amyloidosis (ATTR) Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Transthyretin Amyloidosis (ATTR) Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Transthyretin Amyloidosis (ATTR) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Transthyretin Amyloidosis (ATTR) Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Transthyretin Amyloidosis (ATTR) Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Transthyretin Amyloidosis (ATTR) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Transthyretin Amyloidosis (ATTR) Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Transthyretin Amyloidosis (ATTR) Market Size by Country (2026-2031) & (US$ Million)
Table 46. Pfizer Company Details
Table 47. Pfizer Business Overview
Table 48. Pfizer Transthyretin Amyloidosis (ATTR) Product
Table 49. Pfizer Revenue in Transthyretin Amyloidosis (ATTR) Business (2020-2025) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. Alnylam Pharmaceuticals Company Details
Table 52. Alnylam Pharmaceuticals Business Overview
Table 53. Alnylam Pharmaceuticals Transthyretin Amyloidosis (ATTR) Product
Table 54. Alnylam Pharmaceuticals Revenue in Transthyretin Amyloidosis (ATTR) Business (2020-2025) & (US$ Million)
Table 55. Alnylam Pharmaceuticals Recent Development
Table 56. Ionis Pharmaceuticals Company Details
Table 57. Ionis Pharmaceuticals Business Overview
Table 58. Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Product
Table 59. Ionis Pharmaceuticals Revenue in Transthyretin Amyloidosis (ATTR) Business (2020-2025) & (US$ Million)
Table 60. Ionis Pharmaceuticals Recent Development
Table 61. Corino Therapeutics Company Details
Table 62. Corino Therapeutics Business Overview
Table 63. Corino Therapeutics Transthyretin Amyloidosis (ATTR) Product
Table 64. Corino Therapeutics Revenue in Transthyretin Amyloidosis (ATTR) Business (2020-2025) & (US$ Million)
Table 65. Corino Therapeutics Recent Development
Table 66. Proclara Bioscience Company Details
Table 67. Proclara Bioscience Business Overview
Table 68. Proclara Bioscience Transthyretin Amyloidosis (ATTR) Product
Table 69. Proclara Bioscience Revenue in Transthyretin Amyloidosis (ATTR) Business (2020-2025) & (US$ Million)
Table 70. Proclara Bioscience Recent Development
Table 71. Arcturus Therapeutics Company Details
Table 72. Arcturus Therapeutics Business Overview
Table 73. Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Product
Table 74. Arcturus Therapeutics Revenue in Transthyretin Amyloidosis (ATTR) Business (2020-2025) & (US$ Million)
Table 75. Arcturus Therapeutics Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
Table 79. Authors List of This Report
List of Figures
Figure 1. Transthyretin Amyloidosis (ATTR) Picture
Figure 2. Global Transthyretin Amyloidosis (ATTR) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Transthyretin Amyloidosis (ATTR) Market Share by Type: 2024 VS 2031
Figure 4. Hereditary ATTR (HATTR) Features
Figure 5. Wild-Type (WT) ATTR Features
Figure 6. Global Transthyretin Amyloidosis (ATTR) Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Transthyretin Amyloidosis (ATTR) Market Share by Application: 2024 VS 2031
Figure 8. Hospitals Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Diagnostic Centers Case Studies
Figure 11. Transthyretin Amyloidosis (ATTR) Report Years Considered
Figure 12. Global Transthyretin Amyloidosis (ATTR) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Transthyretin Amyloidosis (ATTR) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Transthyretin Amyloidosis (ATTR) Market Share by Region: 2024 VS 2031
Figure 15. Global Transthyretin Amyloidosis (ATTR) Market Share by Players in 2024
Figure 16. Global Top Transthyretin Amyloidosis (ATTR) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transthyretin Amyloidosis (ATTR) as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Transthyretin Amyloidosis (ATTR) Revenue in 2024
Figure 18. North America Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Transthyretin Amyloidosis (ATTR) Market Share by Country (2020-2031)
Figure 20. United States Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Transthyretin Amyloidosis (ATTR) Market Share by Country (2020-2031)
Figure 24. Germany Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Transthyretin Amyloidosis (ATTR) Market Share by Region (2020-2031)
Figure 32. China Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Transthyretin Amyloidosis (ATTR) Market Share by Country (2020-2031)
Figure 40. Mexico Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Transthyretin Amyloidosis (ATTR) Market Share by Country (2020-2031)
Figure 44. Turkey Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Pfizer Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2020-2025)
Figure 48. Alnylam Pharmaceuticals Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2020-2025)
Figure 49. Ionis Pharmaceuticals Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2020-2025)
Figure 50. Corino Therapeutics Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2020-2025)
Figure 51. Proclara Bioscience Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2020-2025)
Figure 52. Arcturus Therapeutics Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2020-2025)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Table 1. Global Transthyretin Amyloidosis (ATTR) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Hereditary ATTR (HATTR)
Table 3. Key Players of Wild-Type (WT) ATTR
Table 4. Global Transthyretin Amyloidosis (ATTR) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Transthyretin Amyloidosis (ATTR) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Transthyretin Amyloidosis (ATTR) Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Transthyretin Amyloidosis (ATTR) Market Share by Region (2020-2025)
Table 8. Global Transthyretin Amyloidosis (ATTR) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Transthyretin Amyloidosis (ATTR) Market Share by Region (2026-2031)
Table 10. Transthyretin Amyloidosis (ATTR) Market Trends
Table 11. Transthyretin Amyloidosis (ATTR) Market Drivers
Table 12. Transthyretin Amyloidosis (ATTR) Market Challenges
Table 13. Transthyretin Amyloidosis (ATTR) Market Restraints
Table 14. Global Transthyretin Amyloidosis (ATTR) Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Transthyretin Amyloidosis (ATTR) Market Share by Players (2020-2025)
Table 16. Global Top Transthyretin Amyloidosis (ATTR) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transthyretin Amyloidosis (ATTR) as of 2024)
Table 17. Ranking of Global Top Transthyretin Amyloidosis (ATTR) Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Transthyretin Amyloidosis (ATTR) Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Transthyretin Amyloidosis (ATTR), Headquarters and Area Served
Table 20. Global Key Players of Transthyretin Amyloidosis (ATTR), Product and Application
Table 21. Global Key Players of Transthyretin Amyloidosis (ATTR), Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Transthyretin Amyloidosis (ATTR) Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Type (2020-2025)
Table 25. Global Transthyretin Amyloidosis (ATTR) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Type (2026-2031)
Table 27. Global Transthyretin Amyloidosis (ATTR) Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Application (2020-2025)
Table 29. Global Transthyretin Amyloidosis (ATTR) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Application (2026-2031)
Table 31. North America Transthyretin Amyloidosis (ATTR) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Transthyretin Amyloidosis (ATTR) Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Transthyretin Amyloidosis (ATTR) Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Transthyretin Amyloidosis (ATTR) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Transthyretin Amyloidosis (ATTR) Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Transthyretin Amyloidosis (ATTR) Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Transthyretin Amyloidosis (ATTR) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Transthyretin Amyloidosis (ATTR) Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Transthyretin Amyloidosis (ATTR) Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Transthyretin Amyloidosis (ATTR) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Transthyretin Amyloidosis (ATTR) Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Transthyretin Amyloidosis (ATTR) Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Transthyretin Amyloidosis (ATTR) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Transthyretin Amyloidosis (ATTR) Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Transthyretin Amyloidosis (ATTR) Market Size by Country (2026-2031) & (US$ Million)
Table 46. Pfizer Company Details
Table 47. Pfizer Business Overview
Table 48. Pfizer Transthyretin Amyloidosis (ATTR) Product
Table 49. Pfizer Revenue in Transthyretin Amyloidosis (ATTR) Business (2020-2025) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. Alnylam Pharmaceuticals Company Details
Table 52. Alnylam Pharmaceuticals Business Overview
Table 53. Alnylam Pharmaceuticals Transthyretin Amyloidosis (ATTR) Product
Table 54. Alnylam Pharmaceuticals Revenue in Transthyretin Amyloidosis (ATTR) Business (2020-2025) & (US$ Million)
Table 55. Alnylam Pharmaceuticals Recent Development
Table 56. Ionis Pharmaceuticals Company Details
Table 57. Ionis Pharmaceuticals Business Overview
Table 58. Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Product
Table 59. Ionis Pharmaceuticals Revenue in Transthyretin Amyloidosis (ATTR) Business (2020-2025) & (US$ Million)
Table 60. Ionis Pharmaceuticals Recent Development
Table 61. Corino Therapeutics Company Details
Table 62. Corino Therapeutics Business Overview
Table 63. Corino Therapeutics Transthyretin Amyloidosis (ATTR) Product
Table 64. Corino Therapeutics Revenue in Transthyretin Amyloidosis (ATTR) Business (2020-2025) & (US$ Million)
Table 65. Corino Therapeutics Recent Development
Table 66. Proclara Bioscience Company Details
Table 67. Proclara Bioscience Business Overview
Table 68. Proclara Bioscience Transthyretin Amyloidosis (ATTR) Product
Table 69. Proclara Bioscience Revenue in Transthyretin Amyloidosis (ATTR) Business (2020-2025) & (US$ Million)
Table 70. Proclara Bioscience Recent Development
Table 71. Arcturus Therapeutics Company Details
Table 72. Arcturus Therapeutics Business Overview
Table 73. Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Product
Table 74. Arcturus Therapeutics Revenue in Transthyretin Amyloidosis (ATTR) Business (2020-2025) & (US$ Million)
Table 75. Arcturus Therapeutics Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
Table 79. Authors List of This Report
List of Figures
Figure 1. Transthyretin Amyloidosis (ATTR) Picture
Figure 2. Global Transthyretin Amyloidosis (ATTR) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Transthyretin Amyloidosis (ATTR) Market Share by Type: 2024 VS 2031
Figure 4. Hereditary ATTR (HATTR) Features
Figure 5. Wild-Type (WT) ATTR Features
Figure 6. Global Transthyretin Amyloidosis (ATTR) Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Transthyretin Amyloidosis (ATTR) Market Share by Application: 2024 VS 2031
Figure 8. Hospitals Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Diagnostic Centers Case Studies
Figure 11. Transthyretin Amyloidosis (ATTR) Report Years Considered
Figure 12. Global Transthyretin Amyloidosis (ATTR) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Transthyretin Amyloidosis (ATTR) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Transthyretin Amyloidosis (ATTR) Market Share by Region: 2024 VS 2031
Figure 15. Global Transthyretin Amyloidosis (ATTR) Market Share by Players in 2024
Figure 16. Global Top Transthyretin Amyloidosis (ATTR) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transthyretin Amyloidosis (ATTR) as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Transthyretin Amyloidosis (ATTR) Revenue in 2024
Figure 18. North America Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Transthyretin Amyloidosis (ATTR) Market Share by Country (2020-2031)
Figure 20. United States Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Transthyretin Amyloidosis (ATTR) Market Share by Country (2020-2031)
Figure 24. Germany Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Transthyretin Amyloidosis (ATTR) Market Share by Region (2020-2031)
Figure 32. China Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Transthyretin Amyloidosis (ATTR) Market Share by Country (2020-2031)
Figure 40. Mexico Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Transthyretin Amyloidosis (ATTR) Market Share by Country (2020-2031)
Figure 44. Turkey Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Pfizer Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2020-2025)
Figure 48. Alnylam Pharmaceuticals Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2020-2025)
Figure 49. Ionis Pharmaceuticals Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2020-2025)
Figure 50. Corino Therapeutics Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2020-2025)
Figure 51. Proclara Bioscience Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2020-2025)
Figure 52. Arcturus Therapeutics Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2020-2025)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232